TGFb (ng/mL) | Granulysin (pg/mL) | IFNg (pg/mL) | |||||||||
| InferrinTM | Lactoferrin | Placebo |
| InferrinTM | Lactoferrin | Placebo |
| InferrinTM | Lactoferrin | Placebo |
Baseline | 25.0 ± 4.9 | 26.9 ± 6.3 | 25.5 ± 6.3 | Baseline | 626.5 ± 261.3 | 626.6 ± 386.8 | 677.5 ± 290.0 | Baseline | 42.2 ± 22.5 | 40.6 ± 22.0 | 43.3 ± 28.6 |
Week 4 | 27.0 ± 8.1 | 28.7 ± 5.1 | 25.6 ± 8.4 | Week 4 | 592.8 ± 230.3 | 654.9 ± 413.6 | 725.5 ± 309.3 | Week 4 | 44.0 ± 26.3 | 43.2 ± 22.1 | 38.8 ± 22.0 |
Week 8 | 28.9 ± 9.3 | 28.4 ± 8.5 | 24.0 ± 6.4 | Week 8 | 613.0 ± 238.7 | 642.4 ± 337.8 | 667.2 ± 333.0 | Week 8 | 43.7 ± 24.9 | 42.6 ± 22.8 | 38.3 ± 23.6 |
Change | 3.9 ± 10.0 | 1.5 ± 9.1 | −1.4 ± 7.2 | Change | −13.4 ± 113.0 | 15.7 ± 149.2 | −15.3 ± 133.0 | Change | 1.5 ± 7.1 | 2.0 ± 9.0 | −5.0 ± 12.0 |
IL6 (pg/mL) | TNFa (pg/mL) | Zonulin (ng/mL) | |||||||||
| InferrinTM | Lactoferrin | Placebo |
| InferrinTM | Lactoferrin | Placebo |
| InferrinTM | Lactoferrin | Placebo |
Baseline | 24.3 ± 38.4 | 13.5 ± 39.7 | 20.4 ± 36.5 | Baseline | 10.9 ± 3.2 | 11.4 ± 4.1 | 9.9 ± 2.4 | Baseline | 40.7 ± 10.8 | 39.2 ± 7.5 | 38.1 ± 6.2 |
Week 4 | 25.3 ± 38.3 | 21.0 ± 46.7 | 13.7 ± 19.8 | Week 4 | 11.1 ± 3.2 | 11.0 ± 2.3 | 8.4 ± 2.5 | Week 4 | 38.3 ± 4.2 | 38.8 ± 8.4 | 38.9 ± 5.4 |
Week 8 | 27.6 ± 43.9 | 14.0 ± 38.5 | 13.3 ± 19.6 | Week 8 | 11.5 ± 3.3 | 11.7 ± 3.5 | 9.9 ± 6.5 | Week 8 | 36.9 ± 3.0 | 33.3 ± 9.9 | 38.9 ± 9.7 |
Change | 3.3 ± 8.1 | 0.5 ± 2.0 | −7.2 ± 22.6 | Change | 0.6 ± 3.3 | 0.4 ± 2.4 | 0.7 ± 5.6 | Change | −3.8 ± 9.2 | 0.1 ± 2.0 | 0.8 ± 7.4 |